This advertisement is brought to you by Talis.

Talas' industry-leading platforms protect critical applications, data and identities,

anywhere at scale with the highest ROI.

That's why the most trusted companies in the world rely on Talis to protect what matters most.

Learn more at talisgroup.com slash cyber.

Here's your midday brief for Thursday, October 30th. I'm Zoe Colkin for the Wall Street Journal.

Novo Nordisk has launched an unsolicited bid valued at up to $9 billion for

Metzara, a developer of obesity treatments. It's an attempt to top the deal Pfizer reached for

Metzara last month, and it could lead to a legal battle. Metzara said Novo's offer was superior

to Pfizer's up to $7.3 billion offer, and it gave Pfizer four days

to negotiate changes to its original proposal. Pfizer said Novo's attempt to unwind its deal

is reckless and unprecedented. Metzeria's share has surged more than 20% in morning trading.

We're exclusively reporting BlackRock's private credit investing arm and other

lenders are trying to recover over $500 million after they say they fell victim to a fraud involving

loan collateral. The lenders accused Ban Kim Brombat, the owner of Telecom Services Company's

broadband telecom in Bridge Voice, a fabricating accounts receivable that were

supposed to be used as loan collateral. Brombas lawyer said he disputes the allegations of fraud.

And Hurricane Melissa, after hitting Jamaica as one of the most powerful Atlantic storms on record

and barreling through Cuba, has now barreled through the Bahamas, bringing

heavy rain and flooding. The country's weather services said that the hurricane, which had left

the islands by midnight, had brought winds close to 100 miles an hour to the central and southeast

Bahamas before heading toward Bermuda. Heads up, an artificial intelligence tool helped us make this episode by creating summaries

...